Performance and clinical validation of the RealStar® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA

Journal of Clinical Virology

Volumn 60, Issue 2, 2014, Pages 168-171

  Corman, Victor Max ^a   Ölschläger, Stephan ^b   Wendtner, Clemens Martin ^c   Drexler, Jan Felix ^a,d   Hess, Markus ^b   Drosten, Christian ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Altona Diagnostics   (Germany)

^c Klinikum Schwabing   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronavirus; Diagnostic assay; MERS CoV; Middle East respiratory syndrome; PCR

Indexed keywords

VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; ENVELOPE GENE; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MERS COV KIT; MIDDLE EAST; MOLECULAR DIAGNOSTICS; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VALIDATION STUDY; VIRUS DETECTION; WORLD HEALTH ORGANIZATION; CORONAVIRUS INFECTIONS; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DIAGNOSIS; PROCEDURES; STANDARD; STANDARDS;

CORONAVIRUS INFECTIONS; CROSS REACTIONS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 84900317601     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.03.012     Document Type: Article

References (19)

1. Bermingham A., Chand M.A., Brown C.S., Aarons E., Tong C., Langrish C., et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 2012, 17(40).
2. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Engl J Med 2012, 367:1814-1820.
3. WHO Middle East respiratory syndrome coronavirus (MERS-CoV) - update 2014.
4. The Who MERS-CoV., Research G. State of knowledge and data gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in humans. PLoS Curr 2013, 5.
5. Penttinen P., Kaasik-Aaslav K., Friaux A., Donachie A., Sudre B., Amato-Gauci A., et al. Taking stock of the first 133 MERS coronavirus cases globally - Is the epidemic changing?. Euro Surveill 2013, 18.
6. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013, 13:745-751.
7. Guery B., Poissy J., el Mansouf L., Séjourné C., Ettahar N., Lemaire X., et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381:2265-2272.
8. Cotten M., Watson S.J., Kellam P., Al-Rabeeah A.A., Makhdoom H.Q., Assiri A., et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013.
9. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013, 13:752-761.
10. Corman V.M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012, 17(39).
11. Corman V.M., Muller M.A., Costabel U., Timm J., Binger T., Meyer B., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012, 17(49).
12. WHO Laboratory testing for Middle East respiratory syndrome coronavirus - interim recommendations 2013.
13. Drosten C., Doerr H.W., Lim W., Stohr K., Niedrig M. SARS molecular detection external quality assurance. Emerg Infect Dis 2004, 10:2200-2203.
14. Aburizaiza A.S., Mattes F.M., Azhar E.I., Hassan A.M., Memish Z.A., Muth D., et al. Investigation of anti-Middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis 2013, 209(2):243-246.
15. Gierer S., Hofmann-Winkler H., Albuali W.H., Bertram S., Al-Rubaish A.M., Yousef A.A., et al. Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia. Emerg Infect Dis 2013, 19:2034-2036.
16. Khuri-Bulos N., Payne D.C., Xiaoyan L., Erdman D., Wang L., Faouri S., et al. Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Clin Microbiol Infect 2013.
17. de Sousa R., Reusken C., Koopmans M. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol 2013, 59(1):4-11.
18. Cotten M., Watson S.J., Zumla A.I., Makhdoom H.Q., Palser A.L., Ong S.H., et al. Spread, circulation, and evolution of the middle East respiratory syndrome coronavirus. mBio 2014, 5(1).
19. Chu D.K.W., Poon L.L.M., Gomaa M.M., Shehata M.M., Perera R.A.P.M., Zeid D.A., et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis [Internet] 2014, 20. [Online ahead of print].